Cefrotil

This classification denotes a cephalosporin antibiotic with the molecular formula C20H22N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 44P98H0A27, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-methyl-8-oxo-7-(((4-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetyl)amino)-, (6r,7r)- but more generally known as cefrotil, which bears US NIH Compound Identifier 68692. European Medicines Agency schedules Cefrotil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07418MIG. The term CEFROTIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). CEFROTIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefrotil under HS 29419000 and SITC 54139. As of Q4 2014, CEFROTIL remains US FDA's Preferred Term for this commodity. Cefrotil bears US NLM identifiers UMLS ID C2699148 and NCI Concept Code C76591. SMILES: S1C2N(C(=O)C2NC(=O)CC2CCC(C3=NCCCN3)CC2)C(=C(C1)C)C(=O)O.